A common SFTPD polymorphism is associated with atherosclerosis and diabetes, and SP-D has been associated with metabolic disorders because of its effects in the endothelium and adipocytes and its obesity-dampening properties. The gene discussed is SFTPD; the disease is obesity due to melanocortin 4 receptor deficiency.